Home / Resources / Regulatory resources

薬事規制

最新のリソース

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power

Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power

Pinnacle 21 Clinical Metadata Repository

Pinnacle 21 臨床メタデータレポジトリ

製品紹介資料

注目コンテンツ

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

オンデマンド・ウェビナー

Upcoming regulatory webinars

ウェビナー

薬事・メディカルライティング向け生成AI

2025年6月25日 – 10am ET/ 2pm GMT

ウェビナー

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

2025年7月9日 – 11am ET

ウェビナー

Transform Your PK/PD Workflow with AI and the Cloud

2025年7月10日 – 11am ET

Latest regulatory blogs

CERTAINTY 2025: The power of Model-Informed Drug Development

SEND V4.0 – What to Expect and When to Expect It

Best Practices for AI Prompt Engineering in Life Sciences

Managing Clinical Metadata for your Vendors, Studies, and Datasets

In case you missed it: CHI + Certara Webinar on Artificial Intelligence (AI) -Powered Model-Informed Drug Development (MIDD)

Using SDTM Data to Produce Patient Narratives

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

2025 Korea CDISC Day

2025年6月24日 – Seoul

展示会・学会

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois

All regulatory resources

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Certara Services, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Publication

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Infectious Disease, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Webinar

Faster Mapping from Source Data to Target SDTM

Certara Products - Pinnacle 21, Webinar

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Certara Products - Phoenix, Certara Products - Pinnacle 21, Certara Services, Clinical Pharmacology, Clinical Trials, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Webinar - Resources LP - Upcoming, Webinar

Transform Your PK/PD Workflow with AI and the Cloud

Certara Products - Phoenix, Webinar - Resources LP - Upcoming, Webinar

PSI 2025 Conference

Certara Products, Certara Services, Conference LP - Latest, Conference

2025 Korea CDISC Day

Conference LP - Latest, Conference

RAPS協賛Webcast: Efficient Personalization: Mastering Style Guides and Lexicons for Tailored Submissions

Certara Services, Webinar

薬事・メディカルライティング向け生成AI

Webinar - Resources LP - Upcoming, Webinar

Pinnacle 21 臨床メタデータレポジトリ

Certara Products - Pinnacle 21, Clinical Metadata Repository, Fact Sheet

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

Certara Products - Simcyp, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, On-Demand Webinar

CERTAINTY 2025: The power of Model-Informed Drug Development

event, Late clinical - blog, Modeling and Simulation, Blog

1
2
3
…
27
›

ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software